Trualt Bioenergy (NSE:TRUALT) EBIT: ₹2,570 Mil (TTM As of Mar. 2026)


NSE:TRUALT Trualt Bioenergy Ltd NSE:TRUALT
42 GF Score
Price ₹466.85
! 8 Warning Signs
View Full Analysis

What is Trualt Bioenergy EBIT?

Trualt Bioenergy NSE:TRUALT +2.96% 42 EBIT is ₹2,570 Mil as of Mar. 2026. GuruFocus rates NSE:TRUALT with a GF Score™ of 42/100. The stock has 8 warning signs investors should review.

Trualt Bioenergy's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹1,272 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2,570 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Trualt Bioenergy's annualized ROC % for the quarter that ended in Mar. 2026 was 8.22%. Trualt Bioenergy's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 16.59%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Trualt Bioenergy's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 4.59%.

Trualt Bioenergy  (NSE:TRUALT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Trualt Bioenergy's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=3832.72 * ( 1 - 27.18% )/( (0 + 33944.591)/ 1 )
=2790.986704/33944.591
=8.22 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0 - ( 0 - max(0, 0 - 0+0))
=0

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=37783.429 - 2721.141 - ( 1117.697 - max(0, 10847.287 - 14787.487+1117.697))
=33944.591

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Trualt Bioenergy's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=5088.2/( ( (0 + max(0, 0)) + (21251.154 + max(9410.448, 0)) )/ 1 )
=5088.2/( ( 0 + 30661.602 )/ 1 )
=5088.2/30661.602
=16.59 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4061.083 + 5284.3 + 4324.407) - (2721.141 + 0 + 1538.201)
=9410.448

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Trualt Bioenergy's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=2570.212/56045.343
=4.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trualt Bioenergy EBIT Related Terms

Trualt Bioenergy EBIT Historical Data

* Premium members only.

The historical data trend for Trualt Bioenergy's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trualt Bioenergy EBIT Chart

Trualt Bioenergy Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 900.42 1,239.49 1,810.66 3,030.54 2,899.79

Trualt Bioenergy Quarterly Data
Mar21 Mar22 Sep22 Mar23 Mar24 Dec24 Mar25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only 0.00 1,223.62 1,498.93 1,298.16 1,272.05

NSE:TRUALT vs VLO, MPC, PSX: EBIT Comparison

For the Oil & Gas Refining & Marketing subindustry, Trualt Bioenergy's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trualt Bioenergy EV-to-EBIT vs Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Trualt Bioenergy's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Trualt Bioenergy's EV-to-EBIT falls into.


NSE:TRUALT
42GF Score
Trualt Bioenergy Ltd NSE:TRUALT
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trualt Bioenergy EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,570 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹2,570 Mil mean?
Trualt Bioenergy (NSE:TRUALT) has a EBIT of ₹2,570 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Trualt Bioenergy.
Is Trualt Bioenergy's EBIT too high?
Trualt Bioenergy's current EBIT is ₹2,570 Mil. Overall, Trualt Bioenergy has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Trualt Bioenergy's EBIT compare to VLO and MPC?
Trualt Bioenergy's EBIT of ₹2,570 Mil can be compared against companies in the Oil & Gas industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Oil & Gas company?
A good EBIT depends on the Oil & Gas industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Trualt Bioenergy. Trualt Bioenergy's current EBIT is ₹2,570 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trualt Bioenergy stock overvalued right now?
Trualt Bioenergy (NSE:TRUALT) has a current EBIT of ₹2,570 Mil. The current EBIT is ₹2,570 Mil. Trualt Bioenergy's overall GF Score™ is 42/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Trualt Bioenergy (NSE:TRUALT), the current EBIT is ₹2,570 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Trualt Bioenergy Business Description

Industry EnergyOil & Gas
Other Exchanges 544545:India
Address No. 26/1, Dr. Rajkumar Road, No S-904/A, 9th Floor, World Trade Center, Brigade Gateway Campus, Bangalore, KA, IND, 560055
Trualt Bioenergy Ltd is a biofuels producer, particularly in the Ethanol sector. As part of its Ethanol production, the company also produces extra neutral alcohol (ENA), the raw material in the production of alcoholic beverages. Its product portfolio also includes dry ice and liquid carbon dioxide (CO2), by-products in the Ethanol production process. The group is engaged in the business of manufacturing, selling ethanol and compressed biogas, and other products derived from distillery processes.
42GF Score

Get the complete analysis for NSE:TRUALT

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹466.85
Price